2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Melanoma: Is There Significant Antitumor Activity for Low-dose Ipilimumab + Pembrolizumab Immediately Following Progression on PD-1 Ab in Melanoma?

0 views
July 17, 2020
Comments 0
Login to view comments. Click here to Login